Bone targeting agents: bisphosphonates

被引：11

作者：

Debiais, Francoise ^{[1
]}

机构：

[1] Univ Poitiers, CHU Poitiers, Serv Rhumatol, F-86021 Poitiers, France

来源：

BULLETIN DU CANCER | 2013年 / 100卷 / 11期

关键词：

bone metastases; bisphosphonates; malignant osteolysis; CANCER ADJUVANT THERAPY; LONG-TERM EFFICACY; BREAST-CANCER; ZOLEDRONIC ACID; AMERICAN-SOCIETY; SOLID TUMORS; DOUBLE-BLIND; TASK-FORCE; METASTASES; PAMIDRONATE;

D O I：

10.1684/bdc.2013.1840

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Malignant tumor osteolysis is a frequent complication in many cancers. It can cause skeletal-related events with alteration of quality of life and survival. Bisphosphonates play an important role in the management of this malignant osteolysis, via an inhibition of osteoclast-mediated bone resorption, and a potential direct antitumor activity. Their use constitutes an important therapeutic advance in patients with bone metastases so as to reduce or delay the appearance of these skeletal events. They are also useful for the treatment of hypercalcemia, which could arise in these patients. Their interest as adjuvant therapy before the onset of bone metastases is currently being evaluated.

引用

页码：1199 / 1206

页数：8

共 32 条

[21] Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer [J].

Rennert, Gad ;

Pinchev, Mila ;

Rennert, Hedy S. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) :3577-3581

[22]

Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO

[23]

2-L

[24] Mechanisms of disease: Mechanisms of bone metastasis [J].

Roodman, GD .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16) :1655-1664

[25] Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion [J].

Rosen, LS ;

Gordon, DH ;

Dugan, W ;

Major, P ;

Eisenberg, PD ;

Provencher, L ;

Kaminski, M ;

Simeone, J ;

Seaman, J ;

Chen, BL ;

Coleman, RE .

CANCER, 2004, 100 (01) :36-43

[26] Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors - A randomized, phase III, double-blind, placebo-controlled trial [J].

Rosen, LS ;

Gordon, D ;

Tchekmedyian, NS ;

Yanagihara, R ;

Hirsh, V ;

Krzakowski, M ;

Pawlicki, M ;

de Souza, P ;

Zheng, M ;

Urbanowitz, G ;

Reitsma, D ;

Seaman, J .

CANCER, 2004, 100 (12) :2613-2621

[27] Bisphosphonates - An update on mechanisms of action and how these relate to clinical efficacy [J].

Russell, R. Graham G. ;

Xia, Zhidao ;

Dunford, James E. ;

Oppermann, Udo ;

Kwaasi, Aaron ;

Hulley, Philippa A. ;

Kavanagh, Kathryn L. ;

Triffitt, James T. ;

Lundy, Mark W. ;

Phipps, Roger J. ;

Barnett, Bobby L. ;

Coxon, Fraser P. ;

Rogers, Michael J. ;

Watts, Nelson B. ;

Ebetino, Frank H. .

SKELETAL BIOLOGY AND MEDICINE, PT B: DISEASE MECHANISMS AND THERAPEUTIC CHALLENGES, 2007, 1117 :209-257

[28] Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer [J].

Saad, F ;

Gleason, DM ;

Murray, R ;

Tchekmedyian, S ;

Venner, P ;

Lacombe, L ;

Chin, JL ;

Vinholes, JJ ;

Goas, JA ;

Zheng, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (11) :879-882

[29] Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research [J].

Shane, Elizabeth ;

Burr, David ;

Ebeling, Peter R. ;

Abrahamsen, Bo ;

Adler, Robert A. ;

Brown, Thomas D. ;

Cheung, Angela M. ;

Cosman, Felicia ;

Curtis, Jeffrey R. ;

Dell, Richard ;

Dempster, David ;

Einhorn, Thomas A. ;

Genant, Harry K. ;

Geusens, Piet ;

Klaushofer, Klaus ;

Koval, Kenneth ;

Lane, Joseph M. ;

McKiernan, Fergus ;

McKinney, Ross ;

Ng, Alvin ;

Nieves, Jeri ;

O'Keefe, Regis ;

Papapoulos, Socrates ;

Sen, Howe Tet ;

van der Meulen, Marjolein C. H. ;

Weinstein, Robert S. ;

Whyte, Michael .

JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (11) :2267-2294

[30] American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer [J].

Van Poznak, Catherine H. ;

Temin, Sarah ;

Yee, Gary C. ;

Janjan, Nora A. ;

Barlow, William E. ;

Biermann, J. Sybil ;

Bosserman, Linda D. ;

Geoghegan, Cindy ;

Hillner, Bruce E. ;

Theriault, Richard L. ;

Zuckerman, Dan S. ;

Von Roenn, Jamie H. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) :1221-1227

← 1 2 3 4 →